Trials / Recruiting
RecruitingNCT05811975
KSX01-TCRT Injection Project in Solid Tumors
IIT Clinical Trial on Tolerance, Safety, and Preliminary Efficacy of KSX01-TCRT Injection in Solid Tumor Subjects
- Status
- Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- TCRx Therapeutics Co.Ltd · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
1\) Safety and efficacy of TCR-T cells in subjects with refractory/relapsed solid tumors. 2) The activation and proliferation of TCR-T cells in the subject, and the survival time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KSX01-TCRT injection | individualization TCR-T cell injection |
Timeline
- Start date
- 2023-03-07
- Primary completion
- 2026-12-31
- Completion
- 2028-12-31
- First posted
- 2023-04-13
- Last updated
- 2023-04-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05811975. Inclusion in this directory is not an endorsement.